RBQM Technology Trends: Shaping the Future of Clinical Trials
In the evolving field of clinical trials, Risk-Based Quality Management (RBQM) emerges as a cornerstone for enhancing trial efficiency...
Moe Alsumidaie
New Insights on How Walgreens Clinical Trials Operate
In a conversation with Ramita Tandon, Walgreens’ Chief Clinical Trials Officer, we explore the company’s cutting-edge strategies to maximize...
Unpacking FDA’s Discussion Paper on AI in Clinical Trials
In a pioneering initiative, the Food and Drug Administration (FDA) has laid out a comprehensive discussion paper focusing on...
How Do In Silico Trials Work? A Brief Guide
In silico methodologies have transformed the landscape of drug development, providing a virtual platform to predict and optimize drug...
New Insights: International Clinical Trial Regulatory Innovation
At the recent Duke-Margolis Institute for Health Policy conference, regulatory experts worldwide gathered to discuss advancements and collaborative strategies...
Cantex Pharma’s Azeliragon Therapy: A Potential Cancer Breakthrough
In this interview, Dr. Stephen Marcus, CEO of Cantex Pharmaceuticals, discusses the innovative cancer therapy, Azeliragon. He explores its...
Industry and FDA Insights on Clinical Trial Regulatory Change
At the Duke-Margolis Institute for Health Policy conference, industry and government leaders delved into the future of clinical trials...
FDA On Clinical Trial Innovation and Regulatory Evolution
The Enhancing Adoption of Innovative Clinical Trial Approaches: FDA Convening conference hosted by Duke Margolis Institute for Health Policy,...
Merck’s Approach to Protocol Development: Building with Purpose:
At the 2024 SCOPE Summit, Laura Galuchie, Senior Director and TransCelerate Program Lead at Merck provided a fresh perspective...
Unlocking New Digital Health Technology in Clinical Trials
In the rapidly evolving landscape of digital health technology in clinical trials (DHT), Jeremy Wyatt, CEO of ActiGraph, envisions...